| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.59 | 7e-50 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.62 | 2e-28 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.34 | 3e-17 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.33 | 6e-17 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.31 | 3e-16 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.33 | 5e-16 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.32 | 2e-15 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.31 | 2e-15 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.24 | 3e-15 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.26 | 2e-14 |